Hmm: Authors retract paper rather than allow discussion of politics of organ donation in China

transplantationOrgan donation in China, particularly the practice of using organs from executed prisoners, which the government pledged to stop by the middle of this year, has been a controversial subject. For a group of authors in that country and the U.S, a letter criticizing their work that introduced “the political situation of organ donation in China” was cause to retract their own paper.

Here’s the notice in question from Transplantation, for a study published three months ago: Continue reading Hmm: Authors retract paper rather than allow discussion of politics of organ donation in China

Immunology researcher with Expression of Concern has cluster of recent retractions, corrections

j heart lung transplantXia Jiahong, an immunology researcher at Huazhong Science and Technology University in Wuhan, China, who had a paper subject to a fascinating Expression of Concern earlier this month, turns out to have had a few other entries in his retraction and correction record recently.

Here’s a retraction in the January 2014 issue of the Journal of Heart and Lung Transplantation, for “Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation,” a paper first published in 2010: Continue reading Immunology researcher with Expression of Concern has cluster of recent retractions, corrections

Bulfone-Paus retraction count grows to 13 with one in Transplantation

Silvia Bulfone-Paus, the Borstel Institute researcher who was forced to step down as institute director and has already retracted 12 papers, has retracted another, this one in Transplantation. Here’s the text of the notice: Continue reading Bulfone-Paus retraction count grows to 13 with one in Transplantation

Retractile dysfunction? Author says journal yanked paper linking Viagra, Cialis to vision problem after legal threats

The British Journal of Ophthalmology has retracted a 2006 paper which purported to show a link between drugs for erectile dysfunction and a rare form of sudden vision loss called non-arteritic anterior ischaemic optic neuropathy, more commonly known as “Viagra blindness.”

That wouldn’t be terribly interesting, except for this: One of the authors of the paper, a researcher at the University of Alabama named Gerald McGwin Jr., told us that the journal retracted the article because it had become a tool in a lawsuit involving Pfizer, which makes Viagra, and, presumably, men who’d developed blindness after taking the drug:

The article just became too much of a pain in the rear end. It became one of those things where we couldn’t provide all the relevant documentation [to the university, which had to provide records for attorneys]

Ultimately, however, McGwin said that the BJO pulled the plug on the paper.

It was really the journal’s decision to take it out of the literature.

The retraction notice is mute on the reason for the retraction of the blindness paper (and, so far, our requests for comment seem to have fallen on deaf ears). Here’s all it says: Continue reading Retractile dysfunction? Author says journal yanked paper linking Viagra, Cialis to vision problem after legal threats